Drospirenone/Ethinylestradiol 3mg/20µg (24/4 Day Regimen)

@article{Fenton2012DrospirenoneEthinylestradiol3,
  title={Drospirenone/Ethinylestradiol 3mg/20µg (24/4 Day Regimen)},
  author={C. Fenton and K. Wellington and Marit D. Moen and D. M. Robinson},
  journal={Drugs},
  year={2012},
  volume={67},
  pages={1749-1765}
}
SummaryAbstractDrospirenone 3mg with ethinylestradiol 20µg (Yaz®) is a low-dose combined oral contraceptive (COC) administered in a regimen of 24 days of active tablets followed by a short hormone-free interval (4 days; 24/4 regimen). Drospirenone, unlike other synthetic progestogens used in COCs, is a 17α-spirolactone derivative and a 17α-spironolactone analogue with antimineralocorticoid and antiandrogenic properties. Drospirenone/ethinylestradiol 3mg/20µg (24/4) is approved in the US for the… Expand
A new oral contraceptive regimen for endometriosis management: preliminary experience with 24/4-day drospirenone/ethinilestradiol 3 mg/20 mcg
Beyaz®: An Oral Contraceptive Fortified with Folate
Nomegestrol Acetate/Estradiol
...
1
2
3
...

References

SHOWING 1-10 OF 50 REFERENCES
Inhibition of ovulation by a novel progestogen (drospirenone) alone or in combination with ethinylestradiol
  • P. Rosenbaum, W. Schmidt, +7 authors R. Heithecker
  • Medicine
  • The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception
  • 2000
Added benefits of drospirenone for compliance
  • J. Foidart
  • Medicine
  • Climacteric : the journal of the International Menopause Society
  • 2005
Ethinylestradiol/Drospirenone
...
1
2
3
4
5
...